scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.19.5.1333 |
P698 | PubMed publication ID | 10323787 |
P2093 | author name string | J Miyagawa | |
K Matsumoto | |||
Y Matsuzawa | |||
S Yamashita | |||
T Nakagawa | |||
M Nishida | |||
Y Nakagawa | |||
R Tamura | |||
S Nozaki | |||
K Kameda-Takemura | |||
A Nakata | |||
P433 | issue | 5 | |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 1333-1339 | |
P577 | publication date | 1999-05-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. | |
P478 | volume | 19 |
Q35758193 | A CD36-dependent signaling cascade is necessary for macrophage foam cell formation |
Q41043010 | A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics |
Q55669624 | A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis. |
Q34176669 | Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis |
Q30441467 | Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage. |
Q35023612 | Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets |
Q39603796 | CD36 and proteoglycan-mediated pathways for (n-3) fatty acid enriched triglyceride-rich particle blood clearance in mouse models in vivo and in peritoneal macrophages in vitro |
Q39933876 | CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI. |
Q24791158 | CD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6). |
Q35988260 | CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis |
Q22253905 | Characterization and expression of a novel alternatively spliced human angiopoietin-2 |
Q37398392 | Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production |
Q37979643 | Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis |
Q36914981 | Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. |
Q37393776 | Divergence of macrophage phagocytic and antimicrobial programs in leprosy |
Q92405257 | Elevated Neuropeptide Y in Endothelial Dysfunction Promotes Macrophage Infiltration and Smooth Muscle Foam Cell Formation |
Q37583467 | Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression |
Q35185322 | Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis |
Q59237393 | Estudio farmacogenómico mediante microarrays en monocitos de pacientes con hiperlipemia familiar combinada tratados con atorvastatina |
Q39755672 | Expression of both N- and C-terminal GFP tagged huCD36 and their discrepancy in OxLDL and pRBC binding on CHO cells |
Q44471149 | Fatty acids modulate the effect of darglitazone on macrophage CD36 expression. |
Q92644590 | Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE-/- mice |
Q37089762 | Hexarelin Signaling to PPARgamma in Metabolic Diseases |
Q37275036 | Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases |
Q64903361 | Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors. |
Q73764245 | IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells |
Q35745526 | Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53. |
Q73224018 | Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions |
Q39968000 | Lipoprotein binding preference of CD36 is altered by filipin treatment |
Q73980422 | Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation |
Q36200878 | Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization |
Q22253929 | Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species |
Q30436299 | Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis |
Q98945391 | Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe |
Q24683083 | Molecular basis of human CD36 gene mutations |
Q24290466 | Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages |
Q37378957 | Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration |
Q90316142 | Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice |
Q37036184 | N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status. |
Q43912961 | Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase |
Q30981897 | Oxidized Lipoprotein Uptake Through the CD36 Receptor Activates the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells. |
Q44288328 | Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor |
Q51498731 | Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. |
Q28205476 | Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors |
Q24297558 | Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis |
Q35541858 | Role of Monocytes in Atherogenesis |
Q27003423 | Role of advanced glycation end products in cellular signaling |
Q40365049 | Scavenging new insights into atherogenesis |
Q28588228 | Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis |
Q39836169 | Studies on Scavenger Receptors under Experimental Hypercholesterolemia: Modulation on Selenium Supplementation |
Q32062998 | TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells |
Q24623151 | Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice |
Q36304170 | Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging |
Q54945060 | The CD36-PPARγ Pathway in Metabolic Disorders. |
Q40730370 | The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein |
Q33585657 | Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications |
Q28219857 | Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes |
Search more.